CRT Defibrillator (CRT-D) Market
Report ID: SQMIG35A3287
Report ID: SQMIG35A3287
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3287 |
Region:
Global |
Published Date: February, 2026
Pages:
157
|Tables:
144
|Figures:
78
Global CRT defibrillator (CRT-D) Market size was valued at USD 487.3 Million in 2024 and is poised to grow from USD 528.23 Million in 2025 to USD 1007.07 Million by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).
Growing prevalence of heart failure, rising aging population, advancements in device technology, increasing clinical validation through major trials, and integration of remote monitoring capabilities are driving demand for CRT Defibrillators (CRT-D).
Technological improvements in battery longevity, lead design, and device miniaturization are also improving patient outcomes and lowering complication rates, which supports wider adoption in both developed and emerging healthcare systems. Increasing clinical acceptance of cardiac resynchronization therapy defibrillators, supported by trials such as MADIT-CRT and COMPANION demonstrating reduced mortality and hospitalization, has encouraged broader guideline inclusion and reimbursement coverage. Integrating remote monitoring into patient management enables continuous telemetry for early detection of arrhythmias and device issues, reducing emergency admissions and follow-up burdens. Real-world programs across Europe and North America reporting fewer clinic visits and lower readmission rates are also expected to create opportunities for CRT-D deployment in Asia-Pacific where scalable telecare can help address shortages of cardiac specialists. Growing incidence of heart failure and the expanding global geriatric population are expected to primarily drive CRT defibrillator (CRT-D) market growth.
On the contrary, high costs of CRT-D implantation and devices, risk of procedural complications, limited accessibility in low-income healthcare systems, and stringent regulatory and reimbursement challenges are anticipated to slow down CRT defibrillator (CRT-D) market penetration in the future.
AI is improving patient selection and clinical outcomes in the CRT-D market by combining multiple data sources to personalize therapy. Machine learning algorithms analyze ECG patterns, cardiac images, and information from devices monitored remotely, helping in predicting the efficacy of cardiac resynchronization therapy for patients. This has encouraged manufacturers and healthcare organizations to adopt analytics platforms and cloud-based monitoring systems for efficiency in workflow and consistency in treatment outcomes.
In February 2026, BIOTRONIK launched the Acticor Sky and Rivacor Sky CRT-D systems. These devices feature advanced algorithms and streamlined diagnostics that support physiologic pacing and enable earlier detection of arrhythmias. Such innovations help clinicians identify suitable patients and optimize therapy, which ultimately supports market growth and adoption.
Market snapshot - 2026-2033
Global Market Size
USD 487.3 Million
Largest Segment
Bi-Ventricular CRT-D
Fastest Growth
Bi-Ventricular CRT-D
Growth Rate
8.4% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global CRT defibrillator (CRT-D) market is segmented by device type, product features, patient type, end user, distribution channel, and region. Based on device type, the market is segmented into Single Chamber CRT-D, Dual Chamber CRT-D, and Bi-Ventricular CRT-D. Based on product features, the market is segmented into wireless monitoring, anti-tachycardia functions, and rate adaptive pacing. Based on patient type, the market is segmented into adult patients, pediatric patients, and geriatric patients. Based on end user, the market is segmented into hospitals, cardiac clinics, and home care. Based on distribution channel, the market is segmented into direct sales, distributors, and online retail. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The Bi-Ventricular CRT-D segment is slated to account for the highest global CRT defibrillator (CRT-D) market share going forward. Simultaneous biventricular pacing combined with defibrillation directly addresses ventricular dyssynchrony and life-threatening arrhythmias, which helps this segment hold sway over others. The device also produces clearer symptomatic and functional improvements that guide clinician preference and institutional purchasing. The integrated approach reduces progressive remodeling and acute decompensation risk, shaping care pathways and referrals; strong clinical acceptance, device compatibility and perceived outcome advantages drive sustained adoption across treatment settings.
However, dual chamber CRT-D is gaining the strongest growth momentum as per this CRT defibrillator (CRT-D) market forecast. Its simpler implantation profile and relevance for patients with atrioventricular conduction issues are helping create new business scope. Evolving dual-lead coordination and programming improvements lower procedural burden and increase clinician confidence, enabling wider adoption in varied care pathways and generating near-term commercialization opportunities.
The wireless monitoring segment is forecasted to spearhead the global CRT defibrillator (CRT-D) market revenue generation in the future. Continuous remote telemetry enables proactive management of CRT-D patients, allowing earlier detection of arrhythmias, which helps cement the dominance of this segment. Use of remote monitoring also reduces clinic burden and unplanned visits while improving workflow efficiency. Integration with telehealth platforms and payor recognition of remote follow-up reinforce procurement preferences for devices offering robust wireless capabilities and end-to-end connectivity.
Meanwhile, anti-tachycardia functions are also seen to be growing at the fastest rate due to better detection algorithms that have improved therapy sequencing to minimize inappropriate shocks while increasing the confidence of physicians for patient safety, thereby increasing the possibilities for device upgrade and value-added services.
To get detailed segments analysis, Request a Free Sample Report
Robust clinical leadership, mature healthcare infrastructure, and a concentrated base of device manufacturers are helping North America spearhead global CRT defibrillator (CRT-D) adoption. The combination of high clinical engagement and device-based heart failure management and active academic research networks and efficient regulatory processes enables hospitals to implement new medical technologies. Hospitals are able to develop specialized cardiac programs because payer systems acknowledge the clinical benefits of device therapies. The partnership between industry and academic institutions and clinical experts creates a system that develops new products while producing strong evidence and simplifying the process of bringing products to market. The combination of these components establishes an ecosystem that maintains technological progress through clinician expertise and institutional strength to ensure this region’s ongoing leadership in the worldwide CRT defibrillator industry through 2033.
Presence of advanced tertiary care centers, strong clinical trial activity, and close alignment between manufacturers and clinical opinion leaders drives high demand for CRT defibrillators in the country. The presence of a reimbursement system that recognizes device-based therapies has enabled hospitals to invest in specialized cardiac services. The presence of a robust interventional cardiology and electrophysiology network has enabled the optimization of device-based therapies across the United States.
Healthcare ecosystem focused on equitable access, strong hospital networks, and growing clinical expertise in heart failure therapies are shaping CRT defibrillator sales in Canada. The provincial model for healthcare delivery facilitates standardization in the use of CRT-D devices. There is a strong partnership between academic hospitals and healthcare suppliers that supports the generation and use of evidence. There is a high level of investment in training clinicians and managing patients that enhances clinician confidence in the use of advanced technology.
Increasing awareness regarding benefits of device-based cardiac therapies and conducive regulatory and clinical environment for the same are shaping CRT defibrillator demand in Europe. Diverse health care system providers and payers are encouraging the focus on the value proposition for implementing effective supply and innovative new technologies in CRT defibrillation. The new potential for cross-border collaboration in this area of technology, combined with enhanced training initiatives for physicians and increased emphasis on post-marketing surveillance, is helping to enhance clinician confidence and to support broader integration into European care pathways. The demand for CRT defibrillator solutions increases due to enhanced guideline-based heart failure management systems which extend patient referral networks and establish dedicated cardiac treatment facilities. The combination of streamlined regulatory procedures with joint clinical research networks enables multiple medical sites to gather clinical data while training healthcare professionals.
Robust medical technology industry, dense hospital network, and significant clinical research activity are supporting CRT defibrillator demand in Germany. This provides a strong platform for both local supply and manufacturing, resulting in a wide range of CRT devices available in the country. This, coupled with a strong system of clinical education and training, provides a strong platform for CRT defibrillator device usage in Germany, making it a leader in the regional CRT defibrillator market.
Centralized healthcare structures, national procurement mechanisms, and strong academic hospital networks help boost CRT defibrillator (CRT-D) procurement in the United Kingdom. Through active adoption of clinical guidelines and active participation in registries, clinician confidence in device-based therapies is promoted. Specialized training programs for clinicians, as well as heart failure pathways, help in a quicker adoption of new device protocols. This environment, along with evidence-based procurement, helps in a quick assimilation of CRT defibrillator technologies into mainstream cardiac care.
Expansion of hospital networks, growing clinical expertise, and alignment between payers and providers on value driven care help shape CRT defibrillator demand in France. Careful purchasing and partnering with suppliers also drive the adoption of CRT-D devices. The combination of clinical dedication and policy support makes the French CRT defibrillator market an emerging market. Academic cardiology centers are enhancing their research in devices and developing a network that supports clinician familiarity.
Expansion of clinical capacity, growing local industry engagement, and evolving regulatory and reimbursement frameworks are positioning Asia Pacific as a highly opportune region for CRT defibrillator suppliers. An increase in regional manufacturing capabilities and overseas supply representative locations have increased the resiliency of the regional supply chain, while also modifying and adapting products to meet regional clinical requirements. Increased training of clinicians and collaboration with clinical research firms via registry studies will increase familiarity and confidence amongst the clinical providers developing and delivering these therapies. As hospitals renovate infrastructures, payers are beginning to recognize the value of these devices, and the region continues to shift from a Secondary role to a more significant global influencer of CRT defibrillator development and implementation.
Developed hospital infrastructure, deep clinical expertise, and culture of early adoption of cardiac technologies are boosting CRT defibrillator demand in Japan. Research institutions and collaborators are also present to help improve the technology and conduct market analysis. The focus on quality and patient management also helps build confidence among clinicians in adopting CRT defibrillator technology innovations in their patient care processes.
Advanced hospitals, vibrant device industry, and cardiac expertise are headlining the demand for CRT defibrillators in South Korea going forward. Close association between hospitals, manufacturers, and researchers can lead to faster adoption of the latest features developed for the devices. Programs undertaken for the development of clinical capabilities can increase the awareness of the clinicians. Focus on integrated care, technology-enabled follow-up, and value-oriented procurement can increase the adoption of CRT defibrillators.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Prevalence Of Heart Failure
The increasing prevalence of heart failure creates a larger patient population to be treated with CRT-D therapy due to the need to find device-based treatment options for managing severe conduction abnormalities. The increasing patient population with severe ventricular dyssynchrony and symptomatic heart failure despite optimal medical therapy creates an increased demand for device therapy referrals. The need for device therapy creates an increased demand for CRT-D evaluation among healthcare practitioners to ensure CRT-D is adopted into clinical practice for the treatment of appropriate patients.
Continuous advancements in technology related to CRT-D systems improve its clinical utility and procedural efficiency, making clinicians confident and likely to use these devices. This is likely to increase perceptions of treatment limitations, making clinicians more likely to recommend CRT-D therapy for patients who need it. The integration of remote monitoring technology and increased compatible imaging capabilities improves perceptions of value among clinicians, which is likely to increase demand for these devices, thus increasing market expansion due to advancements in technology that address previous limitations of these devices.
High Cost And Reimbursement Challenges
The high costs associated with CRT-D devices at the outset and the complicated process for reimbursement also affect CRT-D adoption by limiting access in resource-constrained environments and influencing purchasing decisions. When strict policies and regulations regarding CRT-D use and different rates for different regions are followed by payers, healthcare providers and clinicians tend to focus more on other forms of treatment and wait for clearer funding opportunities for CRT-D implantation. Such economic factors influence CRT-D adoption by affecting procurement and budgeting decisions and influencing clinicians in their referral practices, thus affecting CRT-D adoption in different healthcare environments.
Limited Skilled Implantation Workforce
The specialized process of CRT-D implantation also needs electrophysiologists who are skilled in the process, and any shortages of personnel can affect the rate of adoption. The availability of training for personnel can also affect the rate of adoption of CRT-D devices since some hospitals may be reluctant to introduce CRT-D services because of the quality of procedures that can be performed. The lack of procedures can affect the confidence of personnel, thereby slowing the rate of adoption. Such workforce challenges can restrain the global CRT defibrillator (CRT-D) market outlook.
Request Free Customization of this report to help us to meet your business objectives.
Competitive landscape in the global CRT-D market is intensifying regulatory milestones and device differentiation drive procurement; competition is propelled by clinical trial outcomes and new architectures such as extravascular and leadless systems. Firms pursue M&A and partnerships to secure electrophysiology, remote-monitoring and software capabilities, for example Boston Scientific’s strategic acquisitions and Medtronic’s Aurora EV ICD approvals, while mid-size rivals accelerate regional approvals and manufacturing to challenge incumbents.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, rising prevalence of heart failure and the growing geriatric population are anticipated to drive the demand for CRT Defibrillators (CRT-D) going forward. However, high device and implantation costs along with risks of procedural complications are slated to slow down the adoption of CRT Defibrillators (CRT-D) in the future. North America is slated to spearhead the demand for CRT Defibrillators (CRT-D) owing to strong reimbursement coverage, high awareness of advanced cardiac therapies, and the presence of well-established healthcare infrastructure. Integration of remote monitoring technologies and advancements in device algorithms and physiologic pacing capabilities are anticipated to be key trends driving the CRT Defibrillator (CRT-D) industry going forward.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 487.3 Million |
| Market size value in 2033 | USD 1007.07 Million |
| Growth Rate | 8.4% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the CRT Defibrillator (CRT-D) Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the CRT Defibrillator (CRT-D) Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the CRT Defibrillator (CRT-D) Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the CRT Defibrillator (CRT-D) Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Crt Defibrillator (Crt-D) Market size was valued at USD 487.3 Million in 2024 and is poised to grow from USD 528.23 Million in 2025 to USD 1007.07 Million by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).
Competitive landscape in the global CRT-D market is intensifying as regulatory milestones and device differentiation drive procurement; competition is propelled by clinical trial outcomes and new architectures such as extravascular and leadless systems. Firms pursue M&A and partnerships to secure electrophysiology, remote-monitoring and software capabilities, for example Boston Scientific’s strategic acquisitions and Medtronic’s Aurora EV ICD approvals, while mid-size rivals accelerate regional approvals and manufacturing to challenge incumbents. 'Medtronic', 'Boston Scientific', 'Abbott Laboratories', 'Biotronik', 'Biomed Technologies', 'LivaNova', 'Philips Healthcare', 'Elekta', 'Zoll Medical Corporation', 'St. Jude Medical', 'Medifocus', 'Oscor', 'AtriCure', 'Cardiovascular Systems, Inc.', 'ELA Medical', 'Shiller', 'Sorin Group', 'Neovasc', 'AngioDynamics', 'Cook Medical'
An increasing prevalence of heart failure expands the pool of patients eligible for CRT-D therapy because clinicians seek device based options to manage advanced conduction abnormalities and reduce symptomatic burden. As more individuals present with complex ventricular dyssynchrony and persistent symptoms despite medical therapy, referral rates for device implantation rise. This broader clinical need prompts healthcare providers to prioritize CRT-D evaluation, encouraging adoption in cardiology practice and supporting market demand through sustained clinical decision making that favors device based interventions for appropriate patients.
Remote Monitoring Integration: Increasing adoption of wireless telemetry and cloud-connected platforms is enabling continuous cardiac rhythm and device performance monitoring, improving post-implant follow-up and facilitating proactive management. Payers and providers favor solutions that reduce readmissions and streamline outpatient care pathways, while manufacturers invest in interoperable ecosystems and user-friendly patient interfaces. The shift supports personalized therapy adjustments and remote diagnostics, expanding access across geographies and allowing collaborative care models that integrate hospital systems, home health services, and mobile health applications seamlessly.
Robust clinical leadership, mature healthcare infrastructure, and a concentrated base of device manufacturers are helping North America spearhead global CRT defibrillator (CRT-D) adoption.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
